Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Ç÷Á¤Áõ¾×ÀÇ Ä¡·á Treatment of the Hemospermia

´ëÇѺñ´¢±â°úÇÐȸÁö 1996³â 37±Ç 11È£ p.1295 ~ 1299
±è¿µÁø, Á¤Èñ, ¾ç±¸Çö,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¿µÁø (  ) 
¿¬¼¼´ëÇб³

Á¤Èñ (  ) 
¿¬¼¼´ëÇб³
¾ç±¸Çö (  ) 
¿¬¼¼´ëÇб³

Abstract


To evaluate the etiology and treatment of options in patients with hemospermia, we retrospectively reviewed 21 patients who had both transrectal ultrasound and MRI and have been followed for more than 6 months after initiation of treatment. Mean
age
was 40 years (range 20-50 years) with prostiatic cyst, 9 patients underwent transurethral unroofing (TUUR) of cyst. All 9 patients were completely cured, but one patient developed postoperative epididymitis. Among the 6 patients with prostatitis,
hemospermia was resolved in 4 patients after mean treatment of 12 weeks with antibiotics. In DES (Diethylstilbestrol) group, 50% showed resolution of symptoms among 6 patients after 4 weeks of treatment, and two patients complained breast
discomfort
which were developed after medication.
In conclusion, the antibiotic treatment is advisable in hemospermia patients with prostatitis. Prostatic cystic lesion is believed to be a factor in hemospermia, thus TUUR of cyst wall and removal of stone and hematoma in cyst can be a viable
option.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS